FibroGen, Inc.

ent_019e3f6b75fff6c1bdd65f7da10b6f18

Compliance scorecard →🔔 Follow entity

Disclosures

Leak Site · 1 jurisdiction

Incidents

—

no linked incident in sample

Max affected reported

—

no filed count in sample

Leak-site claims

unverified actor claims

Identity resolution

Canonical name: FibroGen, Inc.
Normalized: fibrogen— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: 549300Q914ULWWY95822
SEC EDGAR CIK: None — not an SEC registrant
Domain: fibrogen.com

Unverified threat-actor claim — not a regulatory filing

Attribution, victim identity, and counts shown here derive from a threat actor's public extortion-blog claims, aggregated by ransomware.live. They have not been validated by the victim or any regulator. Treat them as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.

Disclosure history (1)newest first

GLOBALLeak Siteas victim2024-11-19
FibroGen, Inc. is a biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies to treat serious unmet medical needs. The company focuses on areas such as fibrosis and oncology, with its lead product candidates targeting conditions like chronic kidney disease and anemia. FibroGen harnesses innovative technologies to develop first-in-class therapeutics.